In its Departmental Plan, Health Canada commits to proposing regulatory amendments to enable more innovation in drug clinical trials and make Canada a more attractive place for companies to invest. It also plans to introduce amendments aimed at improving predictability for regulated parties and streamlining authorisation processes for health products, while maintaining safety, effectiveness and quality standards.
Media coverage examining injectable versus oral GLP-1 access pathways reflects growing consumer interest in how format differences influence treatment preferences
Quitting a medication cold turkey may lead to withdrawal symptoms, so its best not to make any changes to your dose until you talk to your healthcare provider
Our team of board-certified physicians and experienced healthcare providers are dedicated to delivering exceptional, patient-centered care in a welcoming and compassionate environment
By taking Mounjaro alongside HRT, women may be able to better counteract some of these menopausal effects: Mounjaros appetite-lowering effect could help overcome increased hunger and food cravings The metabolic benefits of HRT may complement Mounjaros fat-burning effects HRT may help mitigate some of the negative impacts of oestrogen decline on body composition The study published in Menopause found that combining a GLP-1 medication (similar to Mounjaro) and HRT led to an average weight loss of 16%, compared to 12% for those not using HRT
Unlike its influence on CAP-induced TRPV1 activation, exendin 939 did not block or potentiate proton-induced channel activity, even at a concentration approximately 30 times greater than its IC 50 value for inhibiting CAP-induced TRPV1 activity, indicating mode-specific inhibition of exendin 939